Main Menu

Ampio Pharmaceuticals, Inc.

(NYSE: AMPE)

Rigrodsky Law, P.A. is investigating potential claims against the officers and directors of Ampio Pharmaceuticals, Inc. ("Ampio" or the "Company") on behalf of stockholders.  A class action complaint has been filed against Ampio.  The complaint alleges that defendants made materially false and/or misleading statements, and failed to disclose material adverse facts about the Company's business operations and prospects. Specifically, defendants: (i) inflated the Company's true ability to successfully file a Biologics License Application for Ampio; (ii) inflated the results of the AP-013 study and the timing of unblinding the data from the AP-013 study; and (iii) that, as a result, defendants' statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 06/15/2024


* Indicates a required field.

Back to Page